Admera Health completed the acquisition of BioEcho Life Sciences.

Admera Health, a genomic and bioinformatic services provider, completed the acquisition of BioEcho Life Sciences, a nucleic acids extraction and analysis solutions provider. Financial terms were not disclosed. “Our acquisition of BioEcho is a pivotal step in Admera Health’s growth. We are committed to providing our customers with the most advanced technologies. BioEcho’s EchoLUTION platform perfectly complements our NGS services, and together, we will be better equipped to support our customers' research needs,” Yun Zhao, Admera Health CEO.